Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves quality of life

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Addeo, Raffaele ^a   Caraglia, Michele ^a,b   Faiola, Vincenzo ^a   Capasso, Elena ^d   Vincenzi, Bruno ^c   Montella, Liliana ^a   Guarrasi, Rosario ^a   Caserta, Luigi ^a   Del Prete, Salvatore ^a  

^a SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d Senology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; TEMOZOLOMIDE;

ADULT; AGED; ANEMIA; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LIVER TOXICITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION EXPOSURE; RASH; SOLID TUMOR; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

AGED; BRAIN; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DACARBAZINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE;

EID: 33846922770     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-18     Document Type: Article

References (28)

1. Zimm S Wampler GL Stablein D Hazra T Young HF Intra-cerebral metastases in solid tumor patients. Natural history and results of treatment Cancer 1981 48 384-394 10.1002/ 1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8 7237407
2. Cappuzzo F Mazzoni F Maestri Di Stefano A Calandri C Crino L Medical treatment of brain metastases from solid tumours Forum (Genova) 2000 10 137-149 10875975
3. Brady LW Mancall EL Lee DK Neff LB Shockman AT Faust DS Antoniades J Prasasvinichai S Torpie RJ Glassburn JR Radiation therapy for intracranial metastatic neoplasia Radiol Clin Biol 1974 43 40-47 4588901
4. DeAngelis LM Delattre JY Posner JB Radiation-induced dementia in patients cured of brain metastases Neurology 1989 39 789-796 2725874
5. Murray KJ Scott C Greenberg HM Emami B Seider M Vora NL Olson C Whitton A Movsas B Curran W A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104 Int J Radiat Oncol Biol Phys 1997 39 571-574 10.1016/ S0360-3016(97)00341-6 9336134
6. Gaspar LE Scott C Rotman M Asbell S Phillips T Wasserman T McKenna WG Byhardt R Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 1997 37 745-751 10.1016/ S0360-3016(96)00619-0 9128946
7. Langer CJ Mehta MP Current management of brain metastases, with a focus on systemic options J Clin Oncol 2005 23 25 6207-6219 10.1200/ JCO.2005.03.145 16135488
8. Quantin X Khial F Reme-Saumon M Michel FB Pujol JL Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer Lung Cancer 1999 26 35-39 10.1016/S0169-5002(99)00071-9 10574679
9. Van den Bent MJ The role of chemotherapy in brain metastases Eur J Cancer 2003 39 15 2114 10.1016/S0959-8049(03)00577-X 14522368
10. Danson SJ Middleton MR Temozolomide: A novel oral alkylating agent Expert Rev Anticancer Ther 2001 1 13-9 10.1586/14737140.1.1.13 12113120
11. Payne MJ Pratap SE Middleton MR Temozolamide in the treatment of solid tumours: Current results and rationale for dosing/scheduling Critical Rev in Oncol Hematol 2005 53 241-252
12. Plowman J Waud WR Koutsoukos AD Rubinstein LV Moore TD Grever MR Preclinical antitumor activity of temozolomide in mice: Efficacy againsthuman brain tumor xenografts and synergism with 1,3-bis (2-chloroethyl)-1-nitrosourea Cancer Res 1994 54 14 3793-9 8033099
13. Caraglia M Addeo R Costanzo R Montella L Faiola V Marra M Abbruzzese A Palmieri G Budillon A Grillone F Venuta S Tagliaferri P Del Prete S Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours Cancer Chemother Pharmacol 2006 57 1 34-9 10.1007/s00280-005-0001-z 16010592
14. Christodoulou C Bafaloukos D Kosmidis P Samantas E Bamias A Papakostas P Karabelis A Bacoyiannis C Skarlos DV Hellenic Cooperative Oncology Group Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases Ann Oncol 2001 12 249-254 10.1023/A:1008354323167 11300333
15. Abrey LE Olson JD Raizer JJ Mack M Rodavitch A Boutros DY Malkin MG A phase II trial of temozolomide for patients with recurrent or progressive brain metastases J Neurooncol 2001 53 259 265 10.1023/ A:1012226718323 11718258
16. Antonadau D Paraskevaidis M Sarris M Coliarakis N Economou I Karageorgis P Throuvalas N Phase II randomised trial of Temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 2002 20 17 3644-3650 10.1200/JCO.2002.04.140 12202665
17. Verger E Gil M Yaya R Vinolas N Villà S Pujol T Quinto L Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trial Int J Radiat Oncol Biol Phys 2005 61 1 185-191 10.1016/j.ijrobp.2004.04.061 15629610
18. Wedge SR Porteous JK Glaser MG Marcus K Newlands ES In vitro evaluation of temozolomide combined with X-irradiation Anticancer Drugs 1997 8 92-97 10.1097/00001813-199701000-00013 9147618
19. Simon R Optimal two-stage designs for phase II clinical trials Control Clin Trials 1989 10 1-10 10.1016/0197-2456(89)90015-9 2702835
20. Kaplan E Meier P Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53 457-481 10.2307/2281868
21. Vantongelen K (eds) A Practical Guide to EORTC Studies: Evaluation, Criteria, Scoring Scales and Instruments Brussels, EORTC 1994 119-131
22. Cella DF Tulsky DS Gray G Sarafian B Linn E Bonomi A Silberman M Yellen SB Winicour P Brannon J The functional assessment of cancer therapy scale: Development and validation of the general measure J Clin Oncol 1993 11 570-579 8445433
23. Weitzner MA Meyers CA Gelke CK Byrne KS Cella DF Levin VA The Functional Assessment of Cancer Therapy (FACT) Scale: Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors Cancer 1995 75 1151-1161 10.1002/ 1097-0142(19950301)75:5<1151::AID-CNCR2820750515>3.0.CO;2-Q 7850714
24. Kalkanis SN Quiñones-Hinojosa A Buzney E Ribaudo HJ Black McL Quality of life following surgery for intracranial meningiomas at Brighamand Women's Hospital: A study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire J Neuro-Oncol 2000 48 233-241 10.1023/A:1006476604338
25. Tosoni A Ermani M Brandes AA The pathogenesis and treatment of brain metastases: A comprehensive review Critical Rev Oncol Hematol 2004 52 199-215
26. Robinet G Thomas P Breton Jl Lena H Gouva S Dabouis G Bennouna J Souquet PJ Balmes P Thiberville L Fournel P Quoix E Riou R Rebattu P Perol M Paillotin D Mornex F Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in operable brain metastases of non-small-cell lung cancer. Groupe Francais Pneumo-Cancerologie (GFPC) protocol 95-1 Ann Oncol 2001 12 59-67 10.1023/A:1008338312647 11249050
27. Postmus PE Haaxma-Reiche H Smit EF Groen HJ Karnicka H Lewinski T van Meerbeeck J Clerico M Gregor A Curran D Sahmoud T Kirkpatrick A Giaccone G Treatment of brain metastases of small-cell lung cancer: Comparing teniposide with whole-brain radiotherapy-A phase III study of European Organization for the Research and treatment of Cancer Lung Cooperative Group J Clin Oncol 2000 18 3400-3408 11013281
28. Cortot A Geriniere L Robinet G Breton JL Corre R Falchero L Berard H Gimenez C Chavaillon JM Perol M Bombaron P Mercier C Souquet PJ Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: A GLOT-GFPC study Ann Oncol 2006 17 1412-1417 10.1093/annonc/mdl146 16790516